MediRama

Contact us LinkedIn

Resources

Share recent publications on regulatory trends, FDA programs, and oncology clinical trial
strategies, such as articles by MediRama's team on oncology drug development.

Total 132

View More

[EDGE Column] AACR 2026 “New Drug Candidates on the Horizon”(2)

  • 2026.05.20
  • Souce: THE BIO
View More

[EDGE Column] AACR 2026 “New Drug Candidates on the Horizon”

  • 2026.05.13
  • Souce: THE BIO
View More

MediRama brings global QA Expert Jung-Ah Lee on board

  • 2026.05.06
  • Souce: THE BIO
View More

MediRama CEO Hanlim Moon Appointed as New President of the Korean Society for Clinical Pharmacology and Therapeutics

  • 2026.04.21
  • Souce: HITNEWS
View More

[Edge Column] The Evolution of Multiple Myeloma Treatment and J&J’s Contributions

  • 2026.04.08
  • Souce: THE BIO
View More

[EDGE Column] The Evolution of Companion Diagnostics in Oncology Drug Development

  • 2026.04.08
  • Souce: THE BIO
View More

An Analysis of the Companion Diagnostic Approval Case That Helped Make Keytruda a Blockbuster

  • 2026.02.27
  • Souce: HITNEWS
View More

[EDGE Column] FDA Clinical Pharmacology Review Trends and Regulatory Implications for ADC Development

  • 2026.02.10
  • Souce: THE BIO
View More

MediRama’s Analysis of the Characteristics of 13 ADCs Approved by the U.S. FDA Published in an International Academic Journal

  • 2026.01.26
  • Souce: Hankyung Bio Insight
View More

MediRama published a paper in TCP Analyzing FDA Review Documents for Approved ADCs

  • 2026.01.15
  • Souce: THE BIO